Hyperkalemia, defined as serum potassium >5.0mmol/L, is a potentially lethal condition as it hinders muscle function and myocardial excitability, which may contribute to arrhythmias and sudden cardiac deaths. Epidemiological data suggests the global prevalence of hyperkalemia is around 6.3%, but the

Myeloproliferative neoplasms (MPNs) are a group of disorders of the clonal hematopoietic stem cells involving the proliferation of hematopoietic lineages. Conventionally, Philadelphia chromosome (Ph)-negative MPNs comprise polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibro